Intellectus Partners LLC Sells 75 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intellectus Partners LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,355 shares of the medical equipment provider’s stock after selling 75 shares during the period. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $2,139,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of ISRG. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC raised its position in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical during the 1st quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Truist Financial increased their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. Finally, BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $537.80 on Friday. The stock has a market cap of $191.55 billion, a price-to-earnings ratio of 86.46, a PEG ratio of 5.28 and a beta of 1.39. The business has a 50 day simple moving average of $496.95 and a 200 day simple moving average of $455.65. Intuitive Surgical, Inc. has a 52-week low of $291.39 and a 52-week high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.